[HTML][HTML] Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?

IG Schoots, AR Padhani - World journal of urology, 2020 - Springer
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …

[HTML][HTML] Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions

IG Schoots, MJ Roobol - World Journal of Urology, 2020 - Springer
Background and purpose Individualized risk-adapted algorithms in prostate cancer (PCa)
diagnosis using predictive prebiopsy variables in addition to prostate-specific antigen value …

A multiparametric magnetic resonance imaging‐based risk model to determine the risk of significant prostate cancer prior to biopsy

PJ van Leeuwen, A Hayen, JE Thompson… - BJU …, 2017 - Wiley Online Library
Objective To develop and externally validate a predictive model for detection of significant
prostate cancer. Patients and Methods Development of the model was based on a …

External validation and comparison of magnetic resonance imaging-based predictive models for clinically significant prostate cancer

HJ Lee, A Lee, XY Yang, YM Law, HH Huang… - … Oncology: Seminars and …, 2021 - Elsevier
Purpose Several multiparametric magnetic resonance imaging (mpMRI)-based models have
been developed with significant improvements in diagnostic accuracy for clinically …

Prediction of prostate cancer risk among men undergoing combined MRI-targeted and systematic biopsy using novel pre-biopsy nomograms that incorporate MRI …

MA Bjurlin, AB Rosenkrantz, S Sarkar, H Lepor… - Urology, 2018 - Elsevier
Objective To develop nomograms that predict the probability of overall prostate cancer
(PCa) and clinically significant PCa (Gleason≥ 7) on magnetic resonance imaging (MRI) …

Combined clinical parameters and multiparametric magnetic resonance imaging for advanced risk modeling of prostate cancer—patient-tailored risk stratification can …

JP Radtke, M Wiesenfarth, C Kesch, MT Freitag, CD Alt… - European urology, 2017 - Elsevier
Background Multiparametric magnetic resonance imaging (mpMRI) is gaining widespread
acceptance in prostate cancer (PC) diagnosis and improves significant PC (sPC; Gleason …

[HTML][HTML] Does multiparametric magnetic resonance of prostate outperform risk calculators in predicting prostate cancer in biopsy naïve patients?

UG Falagario, G Silecchia, SM Bruno… - Frontiers in …, 2021 - frontiersin.org
Background European Association of Urology (EAU) guidelines recommend using risk-
calculators (RCs), imaging or additional biomarkers in asymptomatic men at risk of prostate …

[HTML][HTML] Magnetic resonance imaging-based predictive models for clinically significant prostate cancer: a systematic review

M Triquell, M Campistol, A Celma, L Regis, M Cuadras… - Cancers, 2022 - mdpi.com
Simple Summary Magnetic resonance imaging (MRI) has allowed the early detection of PCa
to evolve towards clinically significant PCa (csPCa), decreasing unnecessary prostate …

A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for …

L Boesen, FB Thomsen, N Nørgaard… - Prostate Cancer and …, 2019 - nature.com
Background Prostate cancer risk prediction models and multiparametric magnetic
resonance imaging (mpMRI) are used for individualised pre-biopsy risk assessment …

A magnetic resonance imaging–based prediction model for prostate biopsy risk stratification

S Mehralivand, JH Shih, S Rais-Bahrami, A Oto… - JAMA …, 2018 - jamanetwork.com
Importance Multiparametric magnetic resonance imaging (MRI) in conjunction with MRI–
transrectal ultrasound (TRUS) fusion-guided biopsies have improved the detection of …